Business Daily

The 'milestone' vaccine is already having an effect

Nov 10, 2020
Global Research Chief for Pfizer, Mikael Dolsten, discusses the impact of the 'milestone' vaccine with over 90% efficacy in preventing COVID-19. The podcast explores market reactions, future stimulus packages, and inflation concerns. Epidemiologist Peter Horby shares cautious optimism for a world reopening.
Ask episode
Chapters
Transcript
Episode notes